Latest Apoptosis Stories
An experimental drug that works by blocking the export of key control molecules from the nucleus of cancer cells shows promise as a treatment for chronic lymphocytic leukemia (CLL) and other incurable B-cell malignancies.
Suppressing a newly identified and characterized protein involved in regulating cell division could be a novel strategy to fight certain cancers because it stops the malignant cells from dividing and causes them to die quickly.
A long non-coding RNA (lncRNA) prevents programmed cell death during one of the final stages of red blood cell differentiation.
Although Burkitt’s lymphoma is thankfully fairly rare in the general population, it is the most common form of malignancy in children in Equatorial Africa and is very frequent in immunocompromised persons, such as those suffering from AIDS.
Researchers at the University of Southern California have identified two molecules that may be more effective cancer killers than are currently available on the market.
- a slit in a tire to drain away surface water and improve traction.